Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Isaac Teitelbaum to Humans

This is a "connection" page, showing publications Isaac Teitelbaum has written about Humans.

 
Connection Strength
 
 
 
0.536
 
  1. Teitelbaum I. Peritoneal Dialysis. N Engl J Med. 2021 Nov 04; 385(19):1786-1795.
    View in: PubMed
    Score: 0.019
  2. Teitelbaum I, Glickman J, Neu A, Neumann J, Rivara MB, Shen J, Wallace E, Watnick S, Mehrotra R. KDOQI US Commentary on the 2020 ISPD Practice Recommendations for Prescribing High-Quality Goal-Directed Peritoneal Dialysis. Am J Kidney Dis. 2021 02; 77(2):157-171.
    View in: PubMed
    Score: 0.018
  3. Teitelbaum I. Delivering High-Quality Peritoneal Dialysis: What Really Matters? Clin J Am Soc Nephrol. 2020 11 06; 15(11):1663-1665.
    View in: PubMed
    Score: 0.018
  4. Chen CH, Perl J, Teitelbaum I. Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function. Perit Dial Int. 2020 05; 40(3):274-281.
    View in: PubMed
    Score: 0.017
  5. Haivas CD, Teitelbaum I. Eradication of Repeated Episodes of Coagulase-Negative Staphylococcus Peritonitis: a Multipronged Approach. Perit Dial Int. 2019 Nov-Dec; 39(6):568-570.
    View in: PubMed
    Score: 0.017
  6. Ambruso SL, Teitelbaum I. Prevention of Peritoneal Dialysis Drop-Out. Adv Perit Dial. 2018 Nov; 34(2018):19-23.
    View in: PubMed
    Score: 0.016
  7. Teitelbaum I. Crafting the Prescription for Patients Starting Peritoneal Dialysis. Clin J Am Soc Nephrol. 2018 03 07; 13(3):483-485.
    View in: PubMed
    Score: 0.015
  8. Bajo MA, Del Peso G, Teitelbaum I. Peritoneal Membrane Preservation. Semin Nephrol. 2017 01; 37(1):77-92.
    View in: PubMed
    Score: 0.014
  9. Kiser TH, Fish DN, Aquilante CL, Rower JE, Wempe MF, MacLaren R, Teitelbaum I. Evaluation of sulfobutylether-?-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Crit Care. 2015 Feb 03; 19:32.
    View in: PubMed
    Score: 0.012
  10. Teitelbaum I. Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach. Blood Purif. 2015; 39(1-3):70-3.
    View in: PubMed
    Score: 0.012
  11. Teixeira JP, Combs SA, Teitelbaum I. Peritoneal dialysis: update on patient survival. Clin Nephrol. 2015 Jan; 83(1):1-10.
    View in: PubMed
    Score: 0.012
  12. Cozzolino M, Funk F, Rakov V, Phan O, Teitelbaum I. Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide. Curr Drug Metab. 2014; 15(10):953-65.
    View in: PubMed
    Score: 0.011
  13. Cadnapaphornchai MA, Teitelbaum I. Strategies for the preservation of residual renal function in pediatric dialysis patients. Pediatr Nephrol. 2014 May; 29(5):825-36; quiz 832.
    View in: PubMed
    Score: 0.011
  14. Furgeson SB, Teitelbaum I. Basically, dialysis is not good enough. Clin J Am Soc Nephrol. 2013 Feb; 8(2):177-8.
    View in: PubMed
    Score: 0.011
  15. Fuquay R, Teitelbaum I. Care of the patient after renal allograft failure: managing the present and planning for the future. Am J Nephrol. 2012; 36(4):348-54.
    View in: PubMed
    Score: 0.010
  16. Panzer SE, Teitelbaum I. Alternative dialysis strategies with icodextrin. Contrib Nephrol. 2012; 178:11-15.
    View in: PubMed
    Score: 0.010
  17. Elhassan E, Teitelbaum I. Time between peritoneal dialysis catheter insertion and use. Contrib Nephrol. 2012; 178:228-231.
    View in: PubMed
    Score: 0.010
  18. Fuquay R, Teitelbaum I. Transplant outcomes and dialysis modality. Contrib Nephrol. 2012; 178:251-257.
    View in: PubMed
    Score: 0.010
  19. Teitelbaum I. Peritoneal dialysis after cardiothoracic surgery: do it! Perit Dial Int. 2012 Mar-Apr; 32(2):131-3.
    View in: PubMed
    Score: 0.010
  20. Elhassan E, McNair B, Quinn M, Teitelbaum I. Prolonged duration of peritoneal dialysis catheter embedment does not lower the catheter success rate. Perit Dial Int. 2011 Sep-Oct; 31(5):558-64.
    View in: PubMed
    Score: 0.009
  21. Thomas J, Teitelbaum I. Preservation of residual renal function in dialysis patients. Adv Perit Dial. 2011; 27:112-7.
    View in: PubMed
    Score: 0.009
  22. Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010 Nov; 30(11):1117-26.
    View in: PubMed
    Score: 0.009
  23. Kendrick J, Teitelbaum I. Strategies for improving long-term survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010 Jun; 5(6):1123-31.
    View in: PubMed
    Score: 0.009
  24. Goldberg R, Yalavarthy R, Teitelbaum I. Adequacy of peritoneal dialysis: beyond small solute clearance. Contrib Nephrol. 2009; 163:147-154.
    View in: PubMed
    Score: 0.008
  25. Furgeson SB, Teitelbaum I. New treatment options and protocols for peritoneal dialysis-related peritonitis. Contrib Nephrol. 2009; 163:169-176.
    View in: PubMed
    Score: 0.008
  26. Moore R, Teitelbaum I. Preventing burnout in peritoneal dialysis patients. Adv Perit Dial. 2009; 25:92-5.
    View in: PubMed
    Score: 0.008
  27. Yalavarthy R, Teitelbaum I. Peritoneal dialysis adequacy: not just small-solute clearance. Adv Perit Dial. 2008; 24:99-103.
    View in: PubMed
    Score: 0.007
  28. Yalavarthy R, Edelstein CL, Teitelbaum I. Acute renal failure and chronic kidney disease following liver transplantation. Hemodial Int. 2007 Oct; 11 Suppl 3:S7-12.
    View in: PubMed
    Score: 0.007
  29. Weiss AS, Lucia MS, Teitelbaum I. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis. Nat Clin Pract Nephrol. 2007 Feb; 3(2):111-5.
    View in: PubMed
    Score: 0.007
  30. Teitelbaum I. Cloudy peritoneal dialysate: it's not always infection. Contrib Nephrol. 2006; 150:187-194.
    View in: PubMed
    Score: 0.006
  31. Teitelbaum I. Peritoneal dialysis is appropriate for elderly patients. Contrib Nephrol. 2006; 150:240-246.
    View in: PubMed
    Score: 0.006
  32. Van Dijk CM, Ledesma SG, Teitelbaum I. Patient characteristics associated with defects of the peritoneal cavity boundary. Perit Dial Int. 2005 Jul-Aug; 25(4):367-73.
    View in: PubMed
    Score: 0.006
  33. Howard CS, Teitelbaum I. Renal replacement therapy in patients with chronic liver disease. Semin Dial. 2005 May-Jun; 18(3):212-6.
    View in: PubMed
    Score: 0.006
  34. Tegethoff JI, Teitelbaum I, Kiser TH. Rapid and Effective Treatment of Peritonitis in Peritoneal Dialysis Patients with Intravenous Dalbavancin. Am J Case Rep. 2024 Jan 26; 25:e942755.
    View in: PubMed
    Score: 0.006
  35. Perl J, Teitelbaum I, Quinn RR. Of Peritoneal Dialysis Access and Home Dialysis Accessibility. J Am Soc Nephrol. 2024 01 01; 35(1):3-5.
    View in: PubMed
    Score: 0.006
  36. Goldman S, Zhao J, Bieber B, Pisoni RL, Horowitz L, Nessim SJ, Piraino B, Lambie M, Kanjanabuch T, Ito Y, Boudville N, Teitelbaum I, Schreiber M, Perl J. Gastric Acid Suppression Therapy and Its Association with Peritoneal Dialysis-Associated Peritonitis in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Kidney360. 2024 Mar 01; 5(3):370-379.
    View in: PubMed
    Score: 0.006
  37. Colbert JF, Griffin BR, Rolloff K, Erzen CL, Haeger SM, Altmann C, Okamura K, Campbell R, Teitelbaum I, Faubel S. Hepcidin Removal during Continuous Renal Replacement Therapy. Blood Purif. 2024; 53(1):23-29.
    View in: PubMed
    Score: 0.006
  38. Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis. 2003 Nov; 42(5):1082-96.
    View in: PubMed
    Score: 0.006
  39. Al Sahlawi M, Bieber B, Bansal S, Block G, Masud T, Piraino B, Schreiber M, Srivatana V, Teitelbaum I, Khan S, El Shamy O, Watnick S, Garcia L, Pisoni RL, Perl J. Standardized Peritonitis Reporting: A Quality Improvement Initiative of the Optimizing Prevention of Peritoneal Dialysis-Associated Peritonitis in the United States (OPPUS) Study. Am J Kidney Dis. 2024 05; 83(5):692-694.
    View in: PubMed
    Score: 0.006
  40. Teitelbaum I. How much peritoneal dialysis is needed for optimal outcomes? Semin Dial. 2003 Sep-Oct; 16(5):374-5.
    View in: PubMed
    Score: 0.006
  41. Parikh C, Yalavarthy R, Gurevich A, Robinson A, Teitelbaum I. Discrepancies in serum albumin measurements vary by dialysis modality. Ren Fail. 2003 Sep; 25(5):787-96.
    View in: PubMed
    Score: 0.006
  42. Hayat A, Cho Y, Hawley CM, Htay H, Krishnasamy R, Pascoe E, Teitelbaum I, Varnfield M, Johnson DW. Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial. Perit Dial Int. 2023 09; 43(5):374-382.
    View in: PubMed
    Score: 0.005
  43. Sherman DS, Fish DN, Teitelbaum I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis. 2003 Feb; 41(2):269-78.
    View in: PubMed
    Score: 0.005
  44. Mitra A, Teitelbaum I. Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines. Adv Perit Dial. 2003; 19:255-9.
    View in: PubMed
    Score: 0.005
  45. Young EW, Zhao J, Pisoni RL, Piraino BM, Shen JI, Boudville N, Schreiber MJ, Teitelbaum I, Perl J, McCullough K. Peritoneal Dialysis-Associated Peritonitis Trends Using Medicare Claims Data, 2013-2017. Am J Kidney Dis. 2023 02; 81(2):179-189.
    View in: PubMed
    Score: 0.005
  46. Perez L, You Z, Teitelbaum I, Andrews ES, Reddin R, Ramirez-Renteria L, Wilson G, Kendrick J. A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis. BMC Nephrol. 2022 07 09; 23(1):245.
    View in: PubMed
    Score: 0.005
  47. Cheetham MS, Zhao J, McCullough K, Fuller DS, Cho Y, Krishnasamy R, Boudville N, Figueiredo AE, Ito Y, Kanjanabuch T, Perl J, Piraino BM, Pisoni RL, Szeto CC, Teitelbaum I, Woodrow G, Johnson DW. International peritoneal dialysis training practices and the risk of peritonitis. Nephrol Dial Transplant. 2022 04 25; 37(5):937-949.
    View in: PubMed
    Score: 0.005
  48. Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022 Mar; 42(2):110-153.
    View in: PubMed
    Score: 0.005
  49. Vondracek SF, Teitelbaum I, Kiser TH. Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021. Am J Kidney Dis. 2021 09; 78(3):442-458.
    View in: PubMed
    Score: 0.005
  50. Al Sahlawi M, Zhao J, McCullough K, Fuller DS, Boudville N, Ito Y, Kanjanabuch T, Nessim SJ, Piraino BM, Pisoni RL, Teitelbaum I, Woodrow G, Kawanishi H, Johnson DW, Perl J. Variation in Peritoneal Dialysis-Related Peritonitis Outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2022 01; 79(1):45-55.e1.
    View in: PubMed
    Score: 0.005
  51. Glickman JD, Teitelbaum I, Golper TA. Prescribing Home Hemodialysis. Adv Chronic Kidney Dis. 2021 03; 28(2):157-163.
    View in: PubMed
    Score: 0.005
  52. Rocklin MA, Teitelbaum I. Noninfectious causes of cloudy peritoneal dialysate. Semin Dial. 2001 Jan-Feb; 14(1):37-40.
    View in: PubMed
    Score: 0.005
  53. Rocklin MA, Quinn MJ, Teitelbaum I. Cloudy dialysate as a presenting feature of superior vena cava syndrome. Nephrol Dial Transplant. 2000 Sep; 15(9):1455-7.
    View in: PubMed
    Score: 0.004
  54. Perl J, Fuller DS, Boudville N, Kliger AS, Schaubel DE, Teitelbaum I, Warady BA, Neu AM, Patel PR, Piraino B, Schreiber M, Pisoni RL. Optimizing Peritoneal Dialysis-Associated Peritonitis Prevention in the United States: From Standardized Peritoneal Dialysis-Associated Peritonitis Reporting and Beyond. Clin J Am Soc Nephrol. 2020 12 31; 16(1):154-161.
    View in: PubMed
    Score: 0.004
  55. Brown EA, Blake PG, Boudville N, Davies S, de Arteaga J, Dong J, Finkelstein F, Foo M, Hurst H, Johnson DW, Johnson M, Liew A, Moraes T, Perl J, Shroff R, Teitelbaum I, Wang AY, Warady B. International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis. Perit Dial Int. 2020 05; 40(3):244-253.
    View in: PubMed
    Score: 0.004
  56. Sahlawi MA, Wilson G, Stallard B, Manera KE, Tong A, Pisoni RL, Fuller DS, Cho Y, Johnson DW, Piraino B, Schreiber MJ, Boudville NC, Teitelbaum I, Perl J. Peritoneal dialysis-associated peritonitis outcomes reported in trials and observational studies: A systematic review. Perit Dial Int. 2020 03; 40(2):132-140.
    View in: PubMed
    Score: 0.004
  57. Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, Nessim SJ, Piraino BM, Pisoni RL, Robinson BM, Schaubel DE, Schreiber MJ, Teitelbaum I, Woodrow G, Zhao J, Johnson DW. Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020 07; 76(1):42-53.
    View in: PubMed
    Score: 0.004
  58. Esson ML, Quinn MJ, Hudson EL, Teitelbaum I. Subcutaneously tunnelled peritoneal dialysis catheters with delayed externalization: long-term follow-up. Adv Perit Dial. 2000; 16:123-8.
    View in: PubMed
    Score: 0.004
  59. Gutman T, Manera KE, Baumgart A, Johnson DW, Wilkie M, Boudville N, Craig JC, Dong J, Jesudason S, Mehrotra R, Neu A, Shen JI, Van Biesen W, Blake PG, Brunier G, Cho Y, Jefferson N, Lenga I, Mann N, Mendelson AA, Perl J, Sanabria RM, Scholes-Roberston N, Schwartz D, Teitelbaum I, Tong A. "Can I go to Glasgow?" Learnings from patient involvement at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD). Perit Dial Int. 2020 01; 40(1):12-25.
    View in: PubMed
    Score: 0.004
  60. Shen JI, Schreiber MJ, Zhao J, Robinson BM, Pisoni RL, Mehrotra R, Oliver MJ, Tomo T, Tungsanga K, Teitelbaum I, Ghaffari A, Lambie M, Perl J. Attitudes toward Peritoneal Dialysis among Peritoneal Dialysis and Hemodialysis Medical Directors: Are We Preaching to the Right Choir? Clin J Am Soc Nephrol. 2019 07 05; 14(7):1067-1070.
    View in: PubMed
    Score: 0.004
  61. Osorio FV, Teitelbaum I. Mechanisms of defective hydroosmotic response in chronic renal failure. J Nephrol. 1997 Sep-Oct; 10(5):232-7.
    View in: PubMed
    Score: 0.004
  62. Perl J, Dember LM, Bargman JM, Browne T, Charytan DM, Flythe JE, Hickson LJ, Hung AM, Jadoul M, Lee TC, Meyer KB, Moradi H, Shafi T, Teitelbaum I, Wong LP, Chan CT. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol. 2017 May 08; 12(5):839-847.
    View in: PubMed
    Score: 0.004
  63. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016 09 10; 36(5):481-508.
    View in: PubMed
    Score: 0.003
  64. Bieber SD, Burkart J, Golper TA, Teitelbaum I, Mehrotra R. Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review. Am J Kidney Dis. 2014 Jun; 63(6):1027-37.
    View in: PubMed
    Score: 0.003
  65. Schelling JR, Baum KF, Teitelbaum I. Didanosine administration in a human immunodeficiency virus-positive renal transplant patient. Am J Kidney Dis. 1993 Jul; 22(1):60-3.
    View in: PubMed
    Score: 0.003
  66. Cheng SS, Berman GW, Merritt GR, Hendrickse A, Fiegel MJ, Teitelbaum I, Campsen J, Wachs M, Zimmerman M, Mandell MS. The response to methylene blue in patients with severe hypotension during liver transplantation. J Clin Anesth. 2012 Jun; 24(4):324-8.
    View in: PubMed
    Score: 0.003
  67. Warnock DG, Hebbar S, Bargman J, Burkart J, Davies S, Finkelstein FO, Mehrotra R, Ronco C, Teitelbaum I, Urakpo K, Chertow GM. Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis. Contrib Nephrol. 2012; 178:157-163.
    View in: PubMed
    Score: 0.003
  68. Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ, Teitelbaum I, Kovesdy CP, Mehrotra R. Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol. 2012; 35(2):198-208.
    View in: PubMed
    Score: 0.002
  69. Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A. Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Am J Kidney Dis. 2011 Dec; 58(6):879-85.
    View in: PubMed
    Score: 0.002
  70. Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol. 2011 May; 6(5):1049-56.
    View in: PubMed
    Score: 0.002
  71. Howard RL, Millspaugh J, Teitelbaum I. Adult and pediatric peritonitis rates in a home dialysis program: comparison of continuous ambulatory and continuous cycling peritoneal dialysis. Am J Kidney Dis. 1990 Nov; 16(5):469-72.
    View in: PubMed
    Score: 0.002
  72. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009 Jun; 4(6):1089-96.
    View in: PubMed
    Score: 0.002
  73. Veis JH, Hammond WS, Teitelbaum I. Hematuria and proteinuria in a patient with ankylosing spondylitis. Am J Kidney Dis. 1988 Feb; 11(2):196-8.
    View in: PubMed
    Score: 0.002
  74. Coca SG, Bauling P, Schifftner T, Howard CS, Teitelbaum I, Parikh CR. Contribution of acute kidney injury toward morbidity and mortality in burns: a contemporary analysis. Am J Kidney Dis. 2007 Apr; 49(4):517-23.
    View in: PubMed
    Score: 0.002
  75. Astor TL, Weill D, Cool C, Teitelbaum I, Schwarz MI, Zamora MR. Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function. J Heart Lung Transplant. 2005 Dec; 24(12):2091-7.
    View in: PubMed
    Score: 0.002
  76. Fish DN, Teitelbaum I, Abraham E. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother. 2005 Jun; 49(6):2421-8.
    View in: PubMed
    Score: 0.002
  77. Thaler SM, Teitelbaum I, Berl T. "Beer potomania" in non-beer drinkers: effect of low dietary solute intake. Am J Kidney Dis. 1998 Jun; 31(6):1028-31.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)